Papers
1
Total Citations
8
H-Index
1
About
Miyoung Nam is a molecular biologist whose research focuses on chemical genetics, drug target identification, and the mechanisms of bioactive compounds, particularly in fission yeast models. Her most notable contribution is a genome-wide drug-induced haploinsufficient screening approach to identify cellular targets of hydrazinocurcumin (HC), a synthetic curcumin derivative with anti-angiogenic properties. This work, published in 2008 and cited 8 times, provided critical insights into the molecular mechanisms underlying HC’s action, advancing the development of improved pharmacological compounds. By leveraging the power of haploinsufficiency profiling, Nam demonstrated how systematic genetic screens can uncover drug-target interactions that are otherwise elusive. Her research bridges natural product chemistry and functional genomics, offering a template for studying other bioactive molecules. Though her citation count is modest, her methodological contribution to drug discovery—especially in understanding how curcumin analogs work at the molecular level—has been valuable for researchers exploring anti-cancer and anti-angiogenic therapies. Nam’s work exemplifies the importance of model organisms in translational pharmacology and continues to inform the design of next-generation therapeutics.
Research Focus
Key Achievements
Top Papers
- 1